Beverly Dye v. HHS - Tdap, shoulder injury related to vaccine administration (SIRVA) (2022)
Case summary [AI summaries can sometimes make mistakes]
Beverly Dye filed a petition for compensation on February 3, 2021, alleging she suffered a shoulder injury related to vaccine administration (SIRVA) after receiving a Tdap vaccine on September 19, 2019. She stated that she received the vaccine in the United States, suffered residual effects for more than six months, and had not filed a civil action or received other compensation for her injury.
Respondent filed a combined Rule 4(c) Report and Proffer on October 12, 2022, conceding that Petitioner's claim met the Table criteria for SIRVA and that all statutory and jurisdictional requirements were met. Based on Respondent's concession and the evidence, a ruling on entitlement found Petitioner entitled to compensation.
Subsequently, a decision awarding damages was issued on November 14, 2022. Respondent proffered an award of $57,500.00 for pain and suffering, which Petitioner agreed to.
The court awarded Beverly Dye a lump sum payment of $57,500.00 for her pain and suffering.
Source PDFs
USCOURTS-cofc-1_21-vv-00855